Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(14 sites)
Belgium
UZ Leuven, Leuven, Vlaams-Brabant Croatia
Children's Hospital Zagreb, Zagreb Czechia
Fakultni nemocnice v Motole, Pediatricka klinika 2, Prague Greece
Sotiria Thoracic Diseases Hospital, Dpt. of Gastroenterology, Building Z, Athens, Attica Israel
Shaare Zedek Medical Center, Jerusalem Schneider Children's Medical Center of Israel, Petah Tikva Italy
Istituto G Gaslini Ospedale Pediatrico IRCCS, Genova Azienda Ospedaliero Universitaria, Policlinico Gaetano Martino, Messina AOU dell'Universita degli Studi della Campania Luigi Vanvitelli, Naples Azienda Ospedaliero-Universitaria Policlinico Umberto I, Rome IRCCS Materno Infantile Burlo Garofolo, Trieste Poland
Instytut Pomnik-/Centrum Zdrowia dziecka, Warsaw Spain
Hospital Sant Joan de Deu, Esplugues de Llobregat, Barcelona Hospital Universitari I Politecnic La Fe de Valencia, Valencia